leadf
logo-loader
CSE:VPH OTCQB:VPHIF

Valeo Pharma Inc.

Receive alerts
Market:
CSE
Market Cap:
$48.2 m
Price
0.73 CAD
Change
1.39%
52 weeks high
1.53
52 weeks low
0.57

In brief

Valeo Pharma is a Canadian pharmaceutical company dedicated to the commercialization of innovative prescription products in Canada with a focus on Neurodegenerative Diseases, Oncology and Hospital Specialty Products. Headquartered in Kirkland, Quebec, Valeo Pharma has all the required capabilities and the full infrastructure to register and properly manage its growing product portfolio through all stages of commercialization.

Snapshot

The company is focused, though not exclusively, on the fields of neuro-degenerative diseases, cancer and hospital specialty products

Insight Widest with the analysis, Proactive gives perspectives that others don't.

Valeo Pharma gearing up for big growth with its strategy to bring prescription drugs to Canadian market

The specialty pharma group's key commercial activity initially is in-licensing drugs from companies in Europe, Asia, and the US

on 10/6/21